Skip to content

Drug interactions

Everolimus + Lonafarnib

Severity: Major

Everolimus and Lonafarnib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a strong CYP3A4 inhibitor and also inhibits P-gp, so it can substantially raise everolimus exposure. This increases the risk of everolimus toxicity such as stomatitis, infection and pneumonitis.

What this interaction means in plain words

Everolimus and Lonafarnib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Everolimus belongs to Oncology; Lonafarnib belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Lonafarnib inhibits CYP3A4 and P-gp, decreasing everolimus clearance and efflux.

What to do

Avoid the combination if possible; otherwise reduce the everolimus dose and monitor trough concentrations and toxicity closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Everolimus and Lonafarnib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Everolimus with Lonafarnib?

MediHelp rates the interaction as major. Everolimus and Lonafarnib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lonafarnib is a strong CYP3A4 inhibitor and also inhibits P-gp, so it can substantially raise everolimus exposure. This increases the risk of everolimus toxicity such as stomatitis, infection and pneumonitis.

How serious is the interaction between Everolimus and Lonafarnib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible; otherwise reduce the everolimus dose and monitor trough concentrations and toxicity closely.

What other medicines interact with Everolimus?

MediHelp also lists interactions of Everolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Levoketoconazole. The full list is on the Everolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in